Changes and clinical significance of serum MMP-9, TIMP-1, COX-2, and immune levels in patients with asthma

Main Article Content

Hong Ming
Youming Huang
Jinjuan Mao
Hui Wang
Xiufeng Gao
Zhidian Li

Keywords

asthma patients, cyclooxygenase-2, immune function metalloproteinase-9, metalloproteinase inhibitors

Abstract

Objective: To detect serum metalloproteinase-9 (MMP-9), tissue inhibitor of metalloproteinases (TIMP-1), cyclooxygenase-2 (COX-2), and T helper cells 1–T helper cells 2 (Th1–Th2) levels in asthma patients and assess their clinical significance.


Methods: A total of 72 patients experiencing acute asthma (acute group), 66 stable asthma patients (stable group), and 60 healthy volunteers (control group) were included in this study. The levels of TIMP-1, COX-2, and Th1–Th2 in patients with acute asthma were measured following treatment with budesonide aerosol inhalation. In addition, the levels of MMP-9, TIMP-1, COX-2 and Th1–Th2 were compared in patients with different severity of acute asthma before and after treatment.


Results: The serum levels of MMP-9, TIMP-1, and COX-2 showed an increasing trend in the control, stable, and acute groups, while levels of Th1–Th2 showed a sequential decreasing trend, and the differences were statistically significant. Comparison of lung function indexes among the three groups of patients established a negative correlation between serum MMP-9 and its forced vital capacity% predicted (FEV%pred), TIMP-1, and COX-2, and FEV%pred and forced expiratory volume in 1 s–forced vital capacity (FEV1/FVC) levels, but a positive correlation between Th1–Th2 and FEV1/FVC levels in the acute group. A significant difference was observed on comparing the levels of serum MMP-9, TIMP-1, COX-2, and Th1–Th2 in patients with different conditions in the acute group. Specifically, as the condition worsened, a significant increase in serum MMP-9, TIMP-1, and COX-2 levels but a significant decrease in Th1–Th2 levels was observed. After treatment, we observed a significant decrease in serum MMP-9, TIMP-1, and COX-2 levels but a significant increase in Th1–Th2 levels in the acute group.


Conclusion: The serum levels of MMP-9, TIMP-1, COX-2, and Th1–Th2 are valuable indicators reflecting the condition of asthma patients and could be considered promising clinical monitoring indicators.

Abstract 128 | PDF Downloads 210 HTML Downloads 0 XML Downloads 6

References

1. Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, et al. Global initiative for asthma strategy 2021: Executive summary and rationale for key changes. Am J Respir Crit Care Med. 2022;205(1):17–35. 10.1164/rccm.202109-2205PP

2. Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, et al. Global initiative for asthma strategy 2021: Executive summary and rationale for key changes. Eur Respir J. 2022;59(1). 10.1183/13993003.02730-2021

3. Tong X, Yin P, Liu W, Chen S, Geldsetzer P, Long Z, et al. Spatial, temporal and demographic patterns in asthma mortality in China: A systematic analysis from 2014 to 2020. World Allergy Organ J. 2023;16(1):100735. 10.1016/j.waojou.2022.100735

4. Liu TT, Qi JL, Yin J, Gao Q, Xu W, Qiao JJ, et al. Asthma mortality among children and adolescents in China, 2008–2018. World J Pediatr. 2022;18(9):598–606. 10.1007/s12519-022-00548-y

5. Liu S, Cao Y, Du T, Zhi YX. Prevalence of comorbid asthma and related outcomes in COVID-19: A systematic review and meta-analysis. J Aller Clin Immunol Pract. 2021;9(2):693–701. 10.1016/j.jaip.2020.11.054

6. Zhou Y, Pan JJ, Xu RJ, Lu WF, Wang YQ, Liu TT, et al. Asthma mortality attributable to ambient temperatures: A case-crossover study in China. Environ Res. 2022;214. 10.1016/j.envres.2022.114116

7. Varricchi G, Ferri S, Pepys J, Poto R, Spadaro G, Nappi E, et al. Biologics and airway remodeling in severe asthma. Allergy. 2022;77(12):3538–52. 10.1111/all.15473

8. Dong LY, Wang Y, Zheng TT, Pu YN, Ma YB, Qi X, et al. Hypoxic hUCMSC-derived extracellular vesicles attenuate allergic airway inflammation and airway remodeling in chronic asthma mice. Stem Cell Res Ther. 2021;12(1). 10.1186/s13287-020-02072-0

9. Chung FT, Huang HY, Lo CY, Huang YC, Lin CW, He CC, et al. Increased ratio of matrix metalloproteinase-9 (MMP-9)/tissue inhibitor metalloproteinase-1 from alveolar macrophages in chronic asthma with a fast decline in FEV1 at 5-year follow-up. J Clin Med. 2019;8(9). 10.3390/jcm8091451

10. Huang MM, Nasab EM, Athari SS. Immunoregulatory effect of mesenchymal stem cell via mitochondria signaling pathways in allergic asthma. Saudi J Biol Sci. 2021;28(12):6957–62. 10.1016/j.sjbs.2021.07.071

11. Liu LY, Gao Y, Si YH, Liu BH, Liu XY, Li GH, et al. MALT1 in asthma children: A potential biomarker for monitoring exacerbation risk and Th1/Th2 imbalance-mediated inflammation. J Clin Lab Anal. 2022;36(5). 10.1002/jcla.24379

12. Yan XP, Liu H, Li T. Lncrna NEAT1 regulates Th1/Th2 in pediatric asthma by targeting microRNA-217/GATA3. Iran J Public Health. 2023;52(1):106–17. 10.18502/ijph.v52i1.11671

13. Sellers WF. Intravenous and intramuscular therapy in near fatal asthma. A response to Al-Shamrani. Int J Pediatr Adolesc Med. 2020;7(4):209–11. 10.1016/j.ijpam.2020.08.003

14. Jones RCM, Dickson-Spillmann M, Mather MJC, Marks D, Shackell BS. Accuracy of diagnostic registers and manage--ment of chronic obstructive pulmonary disease: The Devon primary care audit. Resp Res. 2008;9. 10.1186/1465--9921-9-62

15. Maurer M, Aygoren-Pursun E, Banerji A, Bernstein JA, Boysen HB, Busse PJ, et al. Consensus on treatment goals in hereditary angioedema: A global Delphi initiative. J Allergy Clin Immun. 2021;148(6):1526–32. 10.1016/j.jaci.2021.05.016

16. Hough KP, Curtiss ML, Blain TJ, Liu RM, Trevor J, Deshane JS, et al. Airway remodeling in asthma. Front Med Lausanne. 2020;7. 10.3389/fmed.2020.00191

17. Joseph C, Tatler AL. Pathobiology of airway remodeling in asthma: The emerging role of integrins. J Asthma Allergy. 2022;15:595–610. 10.2147/JAA.S267222

18. Tam A, Osei ET, Cheung CY, Hughes M, Yang CX, McNagny KM, et al. Hedgehog signaling as a therapeutic target for airway remodeling and inflammation in allergic asthma. Cells (Basel). 2022;11(19). 10.3390/cells11193016

19. Huang D, Sun C, Chen M, Bai S, Zhao X, Wang W, et al. Bergenin ameliorates airway inflammation and remodeling in asthma by activating SIRT1 in macrophages to regulate the NF-kappaB pathway. Front Pharmacol. 2022;13:994878. 10.3389/fphar.2022.994878

20. Zou FF, Zhang JP, Xiang GA, Jiao HB, Gao HM. Association of matrix metalloproteinase 9 (MMP-9) polymorphisms with asthma risk: A meta-analysis. Can Respir J. 2019;2019. 10.1155/2019/9260495

21. Islam R, Dash D, Singh R. Intranasal curcumin and sodium butyrate modulates airway inflammation and fibrosis via HDAC inhibition in allergic asthma. Cytokine. 2022;149. 10.1016/j.cyto.2021.155720

22. Barbaro MPF, Spanevello A, Palladino GP, Salerno FG, Lacedonia D, Carpagnano GE. Exhaled matrix metalloproteinase-9 (MMP-9) in different biological phenotypes of asthma. Eur J Intern Med. 2014;25(1):92–6. 10.1016/j.ejim.2013.08.705

23. Bougault V, Turmel J, Boulet LP. Serum and sputum MMP-9/TIMP-1 in winter sports athletes and swimmers: Relationships with airway function. Biomarkers. 2022;27(2):127–37. 10.1080/1354750X.2021.2020902

24. Lee SY, Kim MH, Kim SH, Ahn T, Kim SW, Kwak YS, et al. Korean red ginseng affects ovalbumin-induced asthma by modulating IL-12, IL-4, and IL-6 levels and the NF-kappaB/COX-2 and PGE(2) pathways. J Ginseng Res. 2021;45(4):482–9. 10.1016/j.jgr.2020.10.001

25. Korczynska-Krawczyk P, Kuprys-Lipinska I, Kupczyk M, Wagrowska-Danilewicz M, Szemraj J, Bienias W, et al. The effect of levocetirizine and montelukast on clinical symptoms, serum level and skin expression of COX-1 and COX-2 enzymes in patients suffering from chronic autoimmune urticaria–A pilot study. Postep Derm Alergol. 2020;37(1):73–80. 10.5114/ada.2018.79731

26. Daham K, James A, Balgoma D, Kupczyk M, Billing B, Lindeberg A, et al. Effects of selective COX-2 inhibition on allergen-induced bronchoconstriction and airway inflammation in asthma. J Allergy Clin Immun. 2014;134(2):306–13. 10.1016/j.jaci.2013.12.002

27. Lee SY, Cho SS, Li Y, Bae CS, Park KM, Park DH. Anti-inflammatory effect of curcuma longa and allium hookeri co-treatment via NF-kappaB and COX-2 pathways. Sci Rep. 2020;10(1):5718. 10.1038/s41598-020-62749-7

28. Abdelaziz MH, Ji XY, Wan J, Abouelnazar FA, Abdelwahab SF, Xu HX. Mycobacterium-induced Th1, helminths-induced Th2 cells and the potential vaccine candidates for allergic asthma: Imitation of natural infection. Front Immunol. 2021;12. 10.3389/fimmu.2021.696734

29. Asayama K, Kobayashi T, D’Alessandro-Gabazza CN, Toda M, Yasuma T, Fujimoto H, et al. Protein S protects against allergic bronchial asthma by modulating Th1/Th2 balance. Allergy. 2020;75(9):2267–78. 10.1111/all.14261

30. Hwang YH, Paik MJ, Yee ST. Diisononyl phthalate induces asthma via modulation of Th1/Th2 equilibrium. Toxicol Lett. 2017;272:49–59. 10.1016/j.toxlet.2017.03.014